Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Sublingual buccal effervescent

a buccal effervescent and sublingual technology, applied in the field of pharmaceutical compositions, can solve the problems of unsatisfactory needs for improving the method of administration, many compounds do not rapidly penetrate the oral mucosa, and are difficult to be easily absorbed per-orally (through the gastrointestinal tract)

Inactive Publication Date: 2005-03-24
CIMA LABS
View PDF53 Cites 28 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"The present invention is about pharmaceutical compositions that contain a medicament and an effervescent agent to improve the absorption of the medicament across the mouth's mucosal membranes. This helps to increase the effectiveness of the medicament."

Problems solved by technology

However, many compounds do not rapidly penetrate the oral mucosa.
The compounds which may be well absorbed per-orally (through the gastrointestinal tract) may not be well absorbed through the mucosa of the mouth because the oral mucosa is less permeable than the intestinal mucosa and it does not offer as big a surface area as the small intestine.
Despite these and other efforts toward increasing the permeation of medicaments across the oral mucosa, there have been unmet needs for improved methods of administrating medicaments across the oral mucosa.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0036] The dosage form should include Fentanyl, an effervescent and pH adjusting substance so that the pH is adjusted to neutral (or slightly higher) since the pKa of fentanyl is 7.3. At this pH, the aqueous solubility of this poorly water-soluble drug would not be compromised unduly, and would permit a sufficient concentration of the drug to be present in the unionized form.

[0037] Two fentanyl formulations, each containing 36% effervescence, were produced. These tablets were compressed using half-inch shallow concave punches.

QUANTITYFORMULATIONCOMPONENT(MG)SHORTFentanyl, citrate, USP1.57DISINTEGRATIONLactose monohydrate119.47TIMEMicrocrystalline119.47Cellulose, SilicifiedSodium carbonate,46.99anhydrousSodium bicarbonate105Citric acid, anhydrous75Polyvinylphrrolidone,25cross-linkedMagnesium stearate5Colloidal silicon dioxide2.5Total tablet mass500LONGFentanyl citrate, USP1.57DISINTEGRATIONLactose monohydrate270.93TIMESodium carbonate,40.00anhydrousSodium bicarbonate105Citric acid...

example 2

[0038] The dosage form included prochlorperazine (pKa=8.1), an effervescent and pH adjusting substance so that a slightly higher pH is produced to facilitate the permeation enhancement.

[0039] With respect to prochlorperazine, an anti-emetic drug, two formulations, buccal and sublingual, were developed. The buccal tablets were compressed as quarter inch diameter biconvex tablets, whereas the sublingual tablets were three-eighths inch diameter biconvex tablets. These dimensions were chosen to give a comfortable fit in the respective part of the oral cavity for which they were designed. The formulae for these tablets are as follows:

QUANTITYFORMULATIONCOMPONENT NAME(MG)BUCCALProchlorperazine5.00Sodium Bicarbonate15.52Citric Acid, Anhydrous11.08Sodium Bicarbonate45.78HPMC K4M Prem5.00Dicalcium phosphate5.00dihydrateMannitol11.67Magnesium Stearate0.95Total100.00SUBLINGUALProchlorperazine5.00Sodium Bicarbonate61.25Citric Acid, Anhydrous43.75Sodium Bicarbonate95Sodium carbonate91.25HPMC ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
weight percentaaaaaaaaaa
weight percentaaaaaaaaaa
pKaaaaaaaaaaa
Login to View More

Abstract

A pharmaceutical dosage form adapted to supply a medicament to the oral cavity for buccal, sublingual or gingival absorption of the medicament which contains an orally administrable medicament in combination with an effervescent for use in promoting absorption of the medicament in the oral cavity. The use of an additional pH adjusting substance in combination with the effervescent for promoting the absorption drugs is also disclosed.

Description

CROSS-REFERENCE TO RELATED APPLICATION [0001] The present application is a continuation application of U.S. patent application Ser. No. 10 / 269,669 filed Oct. 11, 2002, which is a divisional application of U.S. patent application Ser. No. 09 / 661,693, filed Sep. 14, 2000, which is a continuation application of U.S. patent application Ser. No. 09 / 327,814 filed Jun. 8, 1999, which is a continuation application of U.S. patent application Ser. No. 09 / 277,424, filed Mar. 26, 1999, which claims the benefit of U.S. Provisional Application No. 60 / 079,652 filed on Mar. 27, 1998, the benefit of which is claimed under 35 U.S.C. § 120 and the disclosure of which is incorporated by reference herein.FIELD OF THE INVENTION [0002] The present invention relates to pharmaceutical compositions, and more particularly to pharmaceutical compositions for oral administration of a medicament, which contain an effervescent agent for enhancing oral drug absorption across the buccal, sublingual, and gingival muc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K9/00A61K9/46A61K31/4468A61K31/5415
CPCA61K9/0007A61K9/0056A61K31/5415A61K31/4468A61K9/006
Inventor PATHER, SATHASIVAN INDIRANKHANKARI, RAJENDRA K.EICHMAN, JONATHAN D.ROBINSON, JOSEPH R.HONTZ, JOHN
Owner CIMA LABS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com